 LA JOLLA, Calif., Nov. 5, 2020 PRNewswire -- Regulus Therapeutics Inc. Nasdaq: RGLS, a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs the Company or Regulus, today reported financial results for the third quarter... 